The high activity levels in PSMA+ LNCaP C4-2 tumor (17.0 ± 10.5) %IA/g and spleen (26.3 ± 15.3) %IA/g were confirmed by γ-counter measurements. The gene discussed is FOLH1; the disease is neoplasm.